Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

October 16, 2023

Study Completion Date

October 16, 2023

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Sofosbuvir-Velpatasvir Drug Combination

One oral pill containing 400mg sofosbuvir and 100mg velpatasvir taken once daily for 12 weeks

Trial Locations (1)

15213

University of Pittsburgh, Magee Womens Hospital, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Catherine Anne Chappell

OTHER